High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To investigate the prevalence and causes of diabetes in patients with primary aldosteronism (PA) in a multi-institutional cohort study in Japan. RESEARCH DESIGN AND METHODS: The prevalence of diabetes was determined in 2,210 patients with PA (diagnosed or glycated hemoglobin [HbA1c] ≥6.5% [≥48 mmol/mol]; NGSP) and compared with that of the Japanese general population according to age and sex. In 1,386 patients with PA and clear laterality (unilateral or bilateral), the effects of plasma aldosterone concentration (PAC), hypokalemia (<3.5 mEq/L), suspected subclinical hypercortisolism (SH; serum cortisol ≥1.8 µg/dL after 1-mg dexamethasone suppression test), and PA laterality on the prevalence of diabetes or prediabetes (5.7% ≤ HbA1c <6.5% [39 mmol/mol ≤ HbA1c <48 mmol/mol]) were examined. RESULTS: Of the 2,210 patients with PA, 477 (21.6%) had diabetes. This prevalence is higher than that in the general population (12.1%) or in 10-year cohorts aged 30–69 years. Logistic regression or χ2 test revealed a significant contribution of suspected SH to diabetes. Despite more active PA profiles (e.g., higher PAC and lower potassium concentrations) in unilateral than bilateral PA, BMI and HbA1c values were significantly higher in bilateral PA. PA laterality had no effect on the prevalence of diabetes; however, the prevalence of prediabetes was significantly higher in bilateral than unilateral PA. CONCLUSIONS: Individuals with PA have a high prevalence of diabetes, which is associated mainly with SH. The prevalence of prediabetes is greater for bilateral than unilateral PA, suggesting a unique metabolic cause of bilateral PA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 4×
“This study was presented in poster form at ENDO 2019, the Endocrine Society’s Annual Meeting, New Orleans, LA, 23–26 March 2019.”
BackgroundInfluentialReport of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, Seino, Y., Nanjo, K., Tajima, N., Kadowaki, T., Kashiwagi, A., Araki, E., Ito, C., Inagaki, N., Iwamoto, Y., et al. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00074.x · Cited by 1,772
Self-citationFassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)
(2014) · Hypertension Research · doi:10.1038/hr.2014.20 · Cited by 1,049
Role for adrenal venous sampling in primary aldosteronism
Young, W. F., Stanson, A. W., Thompson, G. B., Grant, C. S., Farley, D. R., & van Heerden, J. A. (2004) · Surgery · doi:10.1016/j.surg.2004.06.051 · Cited by 735
Nishikawa, T., Omura, M., Satoh, F., Shibata, H., Takahashi, K., Tamura, N., & Tanabe, A. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0133 · Cited by 534
Self-citationThiazide Diuretics, Potassium, and the Development of Diabetes: A Quantitative Review
Zillich, A. J., Garg, J., Basu, S., Bakris, G. L., & Carter, B. L. (2006) · Hypertension · doi:10.1161/01.hyp.0000231552.10054.aa · Cited by 456
Human adipocytes secrete mineralocorticoid-releasing factors
Ehrhart-Bornstein, M., Lamounier-Zepter, V., Schraven, A., Langenbach, J., Willenberg, H. S., Barthel, A., Hauner, H., McCann, S. M., Scherbaum, W. A., & Bornstein, S. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336140100 · Cited by 443 · cited 2×
“factors, namely the older age and higher BMI and triglycerides in patients with bilateral PA, as has also been suggested by previous researchers (36,37).”
BackgroundResultClinical characteristics of primary aldosteronism from an analysis of 145 cases
Conn, J. W., Knopf, R. F., & Nesbit, R. M. (1964) · The American Journal of Surgery · doi:10.1016/0002-9610(64)90252-1 · Cited by 429 · cited 1×
“the basis of the above strict definitions, 505 patients with unilateral and 881 with bilateral PA (1,386) were ultimately included in the determination of effect of laterality on glucose intolerance.”
BackgroundTauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.-A., Fazio, S., & Lombardi, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011766 · Cited by 400
Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1733 · Cited by 372
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
Arlt, W., Lang, K., Sitch, A. J., Dietz, A. S., Rhayem, Y., Bancos, I., Feuchtinger, A., Chortis, V., Gilligan, L. C., Ludwig, P., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93136 · Cited by 281
Insulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study
Catena, C., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G., Novello, M., Favret, G., Melis, A., Cavarape, A., & Sechi, L. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0736 · Cited by 262
Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications
Kalil, G. Z., & Haynes, W. G. (2012) · Hypertension Research · doi:10.1038/hr.2011.173 · Cited by 221 · cited 1×
“to increased sympathetic nerve activity that activates the renin-angiotensinaldosterone system (31,38).”
BackgroundGiacchetti, G., Ronconi, V., Turchi, F., Agostinelli, L., Mantero, F., Rilli, S., & Boscaro, M. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280108e6f · Cited by 196
Rossi, G. P., Belfiore, A., Bernini, G., Fabris, B., Caridi, G., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mannelli, M., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0251 · Cited by 188
Kim, M.-J., Lim, N.-K., Choi, S.-J., & Park, H.-Y. (2015) · Hypertension Research · doi:10.1038/hr.2015.72 · Cited by 158
Shibata, H., & Itoh, H. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2011.245 · Cited by 140 · cited 2×
“As previously reported (31), individuals with unilateral PA had higher PACs and a greater prevalence of hypokalemia than those with”
BackgroundSelf-citationEspiner, E. A., Ross, D. G., Yandle, T. G., Richards, A. M., & Hunt, P. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022051 · Cited by 137 · cited 1×
“and the contralateral ratio (calculated by dividing the aldosterone-to-cortisol ratio on the nondominant side by that in the inferior vena cava) was ,1 after ACTH loading (25,27).”
BackgroundMatrozova, J., Steichen, O., Amar, L., Zacharieva, S., Jeunemaitre, X., & Plouin, P.-F. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.122002 · Cited by 118
Clinicopathological features of primary aldosteronism associated with subclinical Cushing's syndrome
Hiraishi, K., Yoshimoto, T., Tsuchiya, K., Minami, I., Doi, M., Izumiyama, H., Sasano, H., & Hirata, Y. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-402 · Cited by 115
Self-citationEffects of aldosterone on insulin sensitivity and secretion
Luther, J. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.016 · Cited by 114 · cited 1×
“reducing beneficial adipokines such as adiponectin (6,7).”
Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years
Wu, V.-C., Chueh, S.-C. J., Chen, L., Chang, C.-H., Hu, Y.-H., Lin, Y.-H., Wu, K.-D., & Yang, W.-S. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001361 · Cited by 107
Aldosterone Production and Insulin Resistance in Healthy Adults
Garg, R., Hurwitz, S., Williams, G. H., Hopkins, P. N., & Adler, G. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2521 · Cited by 96
Yanase, T., Oki, Y., Katabami, T., Otsuki, M., Kageyama, K., Tanaka, T., Kawate, H., Tanabe, M., Doi, M., Akehi, Y., et al. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej17-0456 · Cited by 90 · cited 2×
“absence of clinical evidence of CS (13).”
MethodSelf-citationUmakoshi, H., Tsuiki, M., Takeda, Y., Kurihara, I., Itoh, H., Katabami, T., Ichijo, T., Wada, N., Yoshimoto, T., Ogawa, Y., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01774 · Cited by 88
Self-citationHayashi, T., Tsumura, K., Suematsu, C., Endo, G., Fujii, S., & Okada, K. (1999) · Diabetes Care · doi:10.2337/diacare.22.10.1683 · Cited by 80
The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism
Šomlóová, Z., Widimský, J., Rosa, J., Wichterle, D., Štrauch, B., Petrák, O., Zelinka, T., Vlková, J., Mašek, M., Dvořáková, J., et al. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.65 · Cited by 68
Kumagai, E., Adachi, H., Jacobs, D. R., Hirai, Y., Enomoto, M., Fukami, A., Otsuka, M., Kumagae, S.-I., Nanjo, Y., Yoshikawa, K., et al. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.180521 · Cited by 65 · cited 1×
“without insulin resistance at baseline (5).”
Ceral, J., Solař, M., Krajina, A., Ballon, M., Šuba, P., & Cap, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0217 · Cited by 56
Primary aldosteronism associated with subclinical Cushing syndrome.
Fujimoto, K., Honjo, S., Tatsuoka, H., Hamamoto, Y., Kawasaki, Y., Matsuoka, A., Ikeda, H., Wada, Y., Sasano, H., & Koshiyama, H. (2013) · PubMed · doi:10.3275/8818 · Cited by 55
Cho, N. H., Kim, K. M., Choi, S. H., Park, K. S., Jang, H. C., Kim, S. S., Sattar, N. A., & Lim, S. K. (2015) · Diabetes Care · doi:10.2337/dc14-1931 · Cited by 53
Krug, A. W., Vleugels, K., Schinner, S., Lamounier‐Zepter, V., Ziegler, C. G., Bornstein, S. R., & Ehrhart‐Bornstein, M. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803642 · Cited by 53
Optimum position of left adrenal vein sampling for subtype diagnosis in primary aldosteronism
Umakoshi, H., Wada, N., Ichijo, T., Kamemura, K., Matsuda, Y., Fuji, Y., Kai, T., Fukuoka, T., Sakamoto, R., Ogo, A., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12847 · Cited by 42
Self-citationAldosterone induces clonal β-cell failure through glucocorticoid receptor
Chen, F., Liu, J., Wang, Y., Wu, T., Shan, W., Zhu, Y., & Han, X. (2015) · Scientific Reports · doi:10.1038/srep13215 · Cited by 34
Primary aldosteronism associated with subclinical Cushing syndrome
Tatsuoka, H., Honjo, S., Hamamoto, Y., Ohgita, Y., Mori, K., Fujimoto, K., Matsuoka, A., Ikeda, H., Wada, Y., Nishikawa, T., et al. (2012) · 15th International & 14th European Congress of Endocrinology · Cited by 26
Cited by
Naruse, M., Katabami, T., Shibata, H., Sone, M., Takahashi, K., Tanabe, A., Izawa, S., Ichijo, T., Otsuki, M., Omura, M., et al. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0508 · Cited by 217
“Aldosterone and cortisol cosecreting adenomas have several clinical characteristics, including larger size (>20 mm) and higher rates of glu‐ cose intolerance, osteoporosis, proteinuria, and cardio‐ vascular events compared with aldosterone-producing adenomas [21, 25, 71-74].”
BackgroundSelf-citationPrimary Aldosteronism: State-of-the-Art Review
Vaidya, A., Hundemer, G. L., Nanba, K., Parksook, W. W., & Brown, J. M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac079 · Cited by 150
Ohya, Y., Arakawa, K., Arata, N., Arima, S., Arima, H., Asayama, K., Dohi, Y., Fukami, A., Furuhashi, M., Goto, K., et al. (2026) · Hypertension Research · doi:10.1038/s41440-025-02462-y · Cited by 106
Self-citationPrimary aldosteronism decreases insulin secretion and increases insulin clearance in humans
Adler, G. K., Murray, G. R., Turcu, A. F., Nian, H., Yu, C., Solorzano, C. C., Manning, R., Peng, D., & Luther, J. M. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.13922 · Cited by 71
Hypokalemia in Diabetes Mellitus Setting
Coregliano-Ring, L., Goia-Nishide, K., & Rangel, É. B. (2022) · Medicina · doi:10.3390/medicina58030431 · Cited by 82
“Among individuals with primary hyperaldosteronism, there is evidence that the prevalence of DM is close to 21%, higher than an estimated 12% prevalence of DM in the general population [27].”
Background
Metadata
- Authors
- Akehi, Y., Yanase, T., Motonaga, R., Umakoshi, H., Tsuiki, M., Takeda, Y., Yoneda, T., Kurihara, I., Itoh, H., Katabami, T., Ichijo, T., Wada, N., Shibayama, Y., Yoshimoto, T., Ashida, K., Ogawa, Y., Kawashima, J., Sone, M., Inagaki, N., Takahashi, K., Fujita, M., Watanabe, M., Matsuda, Y., Kobayashi, H., Shibata, H., Kamemura, K., Otsuki, M., Fujii, Y., Yamamoto, K., Ogo, A., Okamura, S., Miyauchi, S., Fukuoka, T., Izawa, S., Hashimoto, S., Yamada, M., Yoshikawa, Y., Kai, T., Suzuki, T., Kawamura, T., & Naruse, M.
- Affiliations
- Fukuoka University (JP)
- Kyoto Medical Center (JP)
- Kanazawa University (JP)
- Keio University (JP)
- St. Marianna University School of Medicine (JP)
- Department of Endocrinology and Metabolism, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan
- Sapporo City General Hospital (JP)
- Tokyo Medical and Dental University (JP)
- Kyushu University (JP)
- Kumamoto University (JP)
- Kyoto University (JP)
- Showa General Hospital (JP)
- The University of Tokyo (JP)
- Okazaki City Hospital (JP)
- Sanda City Hospital (JP)
- Nihon University (JP)
- Oita University (JP)
- Shinko Hospital (JP)
- The University of Osaka (JP)
- Medical Corporation JR Hiroshima Hospital (JP)
- National Kyushu Medical Center (JP)
- Tenri Hospital (JP)
- Uwajima City Hospital (JP)
- Matsuyama Red Cross Hospital (JP)
- Tottori University Hospital (JP)
- Fukushima Medical University Hospital (JP)
- Gunma University (JP)
- Department of Endocrinology and Diabetes Mellitus, Misato Kenwa Hospital, Misato, Japan
- Saiseikai Tondabayashi Hospital (JP)
- International University of Health and Welfare (JP)
- Corresponding author
- Yanase, Toshihiko
- ORCID
- Yanase, Toshihiko
- Umakoshi, Hironobu
- Tsuiki, Mika
- Takeda, Yoshiyu
- Yoneda, Takashi
- Kurihara, Isao
- Itoh, Hiroshi
- Katabami, Takuyuki
- Ichijo, Takamasa
- Wada, Norio
- Yoshimoto, Takanobu
- Ashida, Kenji
- Ogawa, Yoshihiro
- Kawashima, Junji
- Sone, Masakatsu
- Inagaki, Nobuya
- Fujita, Megumi
- Watanabe, Minemori
- Kobayashi, Hiroki
- Shibata, Hirotaka
- Otsuki, Michio
- Fujii, Yuichi
- Yamamoto, Koichi
- Okamura, Shintaro
- Miyauchi, Shozo
- Izawa, Shoichiro
- Yamada, Masanobu
- Kai, Tatsuya
- Suzuki, Tomoko
- Kawamura, Takashi
- Naruse, Mitsuhide
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-03-27
- Volume
- 42
- Issue
- 5
- Pages
- 938-945
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2939049266
- Cited by
- 95
- References
- 38
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 16 · 2023: 15 · 2022: 24 · 2021: 6 · 2020: 17 · 2019: 3
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (18H01654)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Keywords
- primary aldosteronism, diabetes prevalence, prediabetes, subclinical hypercortisolism, bilateral primary aldosteronism, unilateral primary aldosteronism, aldosterone, hypokalemia, dexamethasone suppression test, HbA1c
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aldosterone, Cushing Syndrome, Diabetes Mellitus, Female, Glycated Hemoglobin, Humans, Hyperaldosteronism, Japan, Male, Middle Aged, Prediabetic State, Retrospective Studies, Cohort Studies, Prevalence, Diabetes Complications, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.